Connectez-vous/S’inscrire
Votre e-mail a été envoyé.
Certaines informations ont été traduites automatiquement.
Informations principales sur l'investissement
- Single Tenant Net Lease Investment Opportunity
Résumé analytique
Ciminelli is pleased to exclusively present the opportunity to acquire a free-standing, single-tenant dialysis facility leased to Fresenius Medical Care (“Fresenius”) with more than 10 years of remaining lease term.
Fresenius has operated at this location since April 2017 and recently executed a new 10-year lease extension commencing April 1, 2027 and expiring March 31, 2037, demonstrating the tenant’s long-term commitment to the site and the mission-critical nature of the facility.
The Property is offered with a modified net lease structure, providing investors with an attractive yield premium relative to traditional absolute net leased assets while maintaining the security of long-term occupancy by one of the world’s leading dialysis providers.
About the Tenant
Fresenius Medical Care (NYSE: FMS) is a global leader in dialysis services and products, operating approximately 3,675 clinics across more than 40 countries. Collectively, these facilities serve approximately 299,000 patients and provide nearly 48 million treatments annually. In the United States alone, Fresenius Kidney Care operates more than 2,200 dialysis centers serving approximately 200,000 patients, representing an estimated 37% share of the U.S. dialysis market.
Fresenius has operated at this location since April 2017 and recently executed a new 10-year lease extension commencing April 1, 2027 and expiring March 31, 2037, demonstrating the tenant’s long-term commitment to the site and the mission-critical nature of the facility.
The Property is offered with a modified net lease structure, providing investors with an attractive yield premium relative to traditional absolute net leased assets while maintaining the security of long-term occupancy by one of the world’s leading dialysis providers.
About the Tenant
Fresenius Medical Care (NYSE: FMS) is a global leader in dialysis services and products, operating approximately 3,675 clinics across more than 40 countries. Collectively, these facilities serve approximately 299,000 patients and provide nearly 48 million treatments annually. In the United States alone, Fresenius Kidney Care operates more than 2,200 dialysis centers serving approximately 200,000 patients, representing an estimated 37% share of the U.S. dialysis market.
Data room Cliquez ici pour accéder à
- Offering Memorandum
Informations sur l’immeuble
Type de vente
Investissement
Type de bien
Bureau
Sous-type de bien
Médical
Surface de l’immeuble
354 m²
Classe d’immeuble
B
Année de construction
1972
Prix
1 226 708 €
Prix par m²
3 469,30 €
Occupation
Mono
Hauteur du bâtiment
1 étage
Surface type par étage
354 m²
Coefficient d’occupation des sols de l’immeuble
0,31
Surface du lot
0,11 ha
Zonage
C-2 - General Commercial & Services
Stationnement
10 places (28,28 places par 1 000 m² loué)
1 1
Assez praticable à pied
50/100
Exceptionnellement adapté aux voitures
100/100
Transports en commun relativement accessibles
40/100
Moyennement praticable en vélo
60/100
Taxes foncières
| Numéro de parcelle | 34-30-15-00000-240-0300 | Évaluation des aménagements | 290 311 € |
| Évaluation du terrain | 174 086 € | Évaluation totale | 464 397 € |
Taxes foncières
Numéro de parcelle
34-30-15-00000-240-0300
Évaluation du terrain
174 086 €
Évaluation des aménagements
290 311 €
Évaluation totale
464 397 €
1 sur 7
Vidéos
Visite extérieure 3D Matterport
Visite 3D
Photos
Street view
Rue
Carte
1 sur 1
Présenté par
6450 Seminole Blvd
Vous êtes déjà membre ? Connectez-vous
Hum, une erreur s’est produite lors de l’envoi de votre message. Veuillez réessayer.
Merci ! Votre message a été envoyé.



